Health Trials

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

ConditionIBS - Irritable Bowel Syndrome
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorTanta University

About this trial

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

Eligibility criteria

Qualifiers

• Age ≥ 18 years,

Man and Women, Negative pregnancy test and effective contraception,

IBS defined by the Rome criteria IV

During the previous seven days the inclusion visit, average numeric rating scale (NRS) pain ≥ 4.

Disqualifiers

• Breastfeeding

Diabetic patients

Significant liver function abnormalities (transaminases> 3N, cholestasis) and moderate renal disease (MDRD <60 ml / min)

Addiction to alcohol and / or drugs,

Trial design

Treatments tested in this trial

  • pentoxyifylline
  • Mebeverine
  • ethosuximide

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Tanta University

Lead sponsor

Source ClinicalTrials.gov